glp-1 supply news today Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Spending Hit $5.8 Billion
Description
The FDA has approved the newest GLP-1ssemaglutide by Novo Nordisk and tirzepatide by Eli Lillyfor multiple indications
Recheck blood work at three months and six months
Its an extraordinarily exciting and busy time in the field of obesity, says Darren McGuire, a cardiologist and professor of internal medicine at University of Texas Southwestern Medical Center
Both treatments are safe, effective and clinically proven- but they work slightly differently
Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes uncontrolled with metformin alone or with sulfonylurea (PIONEER 3)
1.3 kg/m 2 [1.4]
